Where is Cell Therapeutics Commits to PhRMAs Code on Interactions With Health care Professionals?
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today its support of the Pharmaceutical Research Manufacturers of America’s (PhRMA) “Code on Interactions with Healthcare Professionals, revised July 2008” (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies. “As CTI prepares for the potential launch of pixantrone to treat patients with relapsed/refractory aggressive non-Hodgkin’s lymphoma, we are committed to exchanging information with healthcare professionals in an ethical and responsible manner with the patient’s best interests in mind,” stated Craig W. Philips, President of CTI. “Our sales representatives will serve as an important resource for healthcare providers and we are focused on providing information about our therapies in a manner that consistently meets or exceeds PhRMA code guidelines.” The PhRMA Code provides guidance on interactions between U.S. healthcare professionals and biotechnology and pharmaceut
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today its support of the Pharmaceutical Research Manufacturers of America’s (PhRMA) “Code on Interactions with Healthcare Professionals, revised July 2008″ (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.”As CTI prepares for the potential launch of pixantrone to treat patients with relapsed/refractory aggressive non-Hodgkin’s lymphoma, we are committed to exchanging information with healthcare professionals in an ethical and responsible manner with the patient’s best interests in mind,” stated Craig W. Philips, President of CTI. “Our sales representatives will serve as an important resource for healthcare providers and we are focused on providing information about our therapies in a manner that consistently meets or exceeds PhRMA code guidelines.”The PhRMA Code provides guidance on interactions between U.S. healthcare professionals and biotechnology and pharmaceutic
Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America’s “Code on Interactions with Healthcare Professionals, revised July 2008” . Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies. ยป Full Story on Yahoo! Finance Sources: http://us.lrd.yahoo.com/_ylt=Ah71k9Kb5Nfy0_.fzVH_3990fNdF/SIG=11ruh6l2s/**http%3A//biz.yahoo.com/prnews/091222/sf29518.html%3F.
Related Questions
- Does the code of conduct required under the Mass. Rules follow the standards in the PhRMA and AdvaMed Codes for financial relationships with physicians?
- Where can I get more information about FTCA coverage for Free Clinic volunteer health care professionals?
- Where is Cell Therapeutics Commits to PhRMAs Code on Interactions With Health care Professionals?
